Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1954 1
1971 1
1987 1
1988 5
1989 3
1990 5
1991 6
1992 4
1993 1
1994 5
1995 4
1996 5
1997 7
1998 7
1999 18
2000 14
2001 25
2002 46
2003 82
2004 50
2005 35
2006 68
2007 58
2008 32
2009 34
2010 23
2011 28
2012 26
2013 20
2014 18
2015 23
2016 21
2017 41
2018 21
2019 15
2020 9
2021 9
2022 4
2023 5
2024 6
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

718 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for giles f
Search for Gil SF instead (1 results)
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Thomas DA, Faderl S, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles FJ, Verstovsek S, Wierda WG, Pierce SA, Shan J, Brandt M, Hagemeister FB, Keating MJ, Cabanillas F, Kantarjian H. Thomas DA, et al. Among authors: giles fj. Cancer. 2006 Apr 1;106(7):1569-80. doi: 10.1002/cncr.21776. Cancer. 2006. PMID: 16502413 Free article. Clinical Trial.
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ. Kantarjian H, et al. Among authors: giles f. Cancer. 2004 Dec 15;101(12):2788-801. doi: 10.1002/cncr.20668. Cancer. 2004. PMID: 15481055 Free article. Clinical Trial.
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation.
Serra-Camprubí Q, Verdaguer H, Oliveros W, Lupión-Garcia N, Llop-Guevara A, Molina C, Vila-Casadesús M, Turpin A, Neuzillet C, Frigola J, Querol J, Yáñez-Bartolomé M, Castet F, Fabregat-Franco C, Escudero-Iriarte C, Escorihuela M, Arenas EJ, Bernadó-Morales C, Haro N, Giles FJ, Pozo ÓJ, Miquel JM, Nuciforo PG, Vivancos A, Melé M, Serra V, Arribas J, Tabernero J, Peiró S, Macarulla T, Tian TV. Serra-Camprubí Q, et al. Among authors: giles fj. Clin Cancer Res. 2023 Jan 17;29(2):432-445. doi: 10.1158/1078-0432.CCR-22-2551. Clin Cancer Res. 2023. PMID: 36374558 Free PMC article.
Acute myeloid leukemia.
Giles FJ, Keating A, Goldstone AH, Avivi I, Willman CL, Kantarjian HM. Giles FJ, et al. Hematology Am Soc Hematol Educ Program. 2002:73-110. doi: 10.1182/asheducation-2002.1.73. Hematology Am Soc Hematol Educ Program. 2002. PMID: 12446420 Review.
Overcoming immunosuppression in bone metastases.
Reinstein ZZ, Pamarthy S, Sagar V, Costa R, Abdulkadir SA, Giles FJ, Carneiro BA. Reinstein ZZ, et al. Among authors: giles fj. Crit Rev Oncol Hematol. 2017 Sep;117:114-127. doi: 10.1016/j.critrevonc.2017.05.004. Epub 2017 May 12. Crit Rev Oncol Hematol. 2017. PMID: 28600175 Review.
Novel therapies for myelofibrosis.
Stein BL, Cervantes F, Giles F, Harrison CN, Verstovsek S. Stein BL, et al. Among authors: giles f. Leuk Lymphoma. 2015;56(10):2768-78. doi: 10.3109/10428194.2015.1037762. Epub 2015 May 18. Leuk Lymphoma. 2015. PMID: 25860240 Free PMC article. Review.
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial.
Gambacorti-Passerini C, Brümmendorf TH, Abruzzese E, Kelly KR, Oehler VG, García-Gutiérrez V, Hjorth-Hansen H, Ernst T, Leip E, Purcell S, Luscan G, Viqueira A, Giles FJ, Hochhaus A. Gambacorti-Passerini C, et al. Among authors: giles fj. Leukemia. 2024 Oct;38(10):2162-2170. doi: 10.1038/s41375-024-02372-x. Epub 2024 Aug 20. Leukemia. 2024. PMID: 39164407 Free PMC article. Clinical Trial.
Targeted therapy of acute myeloid leukemia.
Carneiro BA, Altman JK, Kaplan JB, Ossenkoppele G, Swords R, Platanias LC, Giles FJ. Carneiro BA, et al. Among authors: giles fj. Expert Rev Anticancer Ther. 2015 Apr;15(4):399-413. doi: 10.1586/14737140.2015.1004316. Epub 2015 Jan 26. Expert Rev Anticancer Ther. 2015. PMID: 25623136 Review.
Laromustine (cloretazine).
Vey N, Giles F. Vey N, et al. Among authors: giles f. Expert Opin Pharmacother. 2010 Mar;11(4):657-67. doi: 10.1517/14656561003621232. Expert Opin Pharmacother. 2010. PMID: 20163276 Review.
718 results